Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. brain structure
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Videos

Refine by
Date

  • Older

Brain Structure Articles & Analysis

22 news found

Alfa Chemistry Provides Supplement Ingredients for Muscle Building, Skincare Health, Weight Loss Management and Brain Health

Alfa Chemistry Provides Supplement Ingredients for Muscle Building, Skincare Health, Weight Loss Management and Brain Health

Omega-3 fatty acids from Alfa Chemistry sustain brain structure and function while ginkgo biloba may enhance brain blood flow and phosphatidylserine improves cognitive ability and memory. ...

ByAlfa Chemistry


Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. ...

BySynaptive Medical


Jubilant Therapeutics Inc. Reports Development of Orally Available and Brain Penetrant Small Molecule Inhibitors of PD-L1 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Jubilant Therapeutics Inc. Reports Development of Orally Available and Brain Penetrant Small Molecule Inhibitors of PD-L1 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

“However, these antibodies have poor brain penetrance and shown limited efficacy in brain cancers. Employing our structure-based drug design and computational algorithms, we have designed oral small molecule checkpoint inhibitors that address this limitation. ...

ByJubilant Therapeutics Inc.


VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

The Total Brain platform helps more than one million individuals improve overall mental health and brain performance using several semi-quantitative functional methods. The company’s data sets represent the world’s largest standardized brain database encompassing human electrical brain function, brain ...

ByVeriSIM Life


BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics

BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics

BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it had concluded both algorithm development and clinical validation studies in adolescent and young adult populations using its objective, EEG-based technology. ...

ByBrainScope Company, Inc.


BrainScope Completes Agreement with 18,000 Member Yankee Alliance

BrainScope Completes Agreement with 18,000 Member Yankee Alliance

” The company's disposable headset connects to its handheld device which acquires, processes, and analyzes thousands of brain activity-based physiological parameters, transforming them into structural and functional indices by using artificial intelligence derived algorithms. ...

ByBrainScope Company, Inc.


BrainScope and Aon Secure IP-based Deal Funding Full Expansion of Commercial Activities and Pursuit of New Indications for BrainScope’s Next-Gen Medical Device Platform

BrainScope and Aon Secure IP-based Deal Funding Full Expansion of Commercial Activities and Pursuit of New Indications for BrainScope’s Next-Gen Medical Device Platform

Aon is working with companies like BrainScope to help them seek access to non-dilutive growth capital by valuing intangible assets and structuring capital solutions that leverage such value. About BrainScope BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. ...

ByBrainScope Company, Inc.


NeuroNav Partners with Axial3D to improve neuronavigation using artificial intelligence

NeuroNav Partners with Axial3D to improve neuronavigation using artificial intelligence

Neurosurgery procedures are extremely complex requiring high precision to avoid damage to vital structures of the brain. Neuronavigation systems help to guide surgeons to perform an even more accurate surgery, decreasing the percentage of serious damage to these vital structures. ...

ByAxial3D


Oxford Brain Diagnostics wins funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostic in NHS

Oxford Brain Diagnostics wins funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostic in NHS

Dr Steven Chance, CEO, Oxford Brain Diagnostics said ‘we are very excited to be working with our partners and the NIHR on this project. ...

ByOxford Brain Diagnostics Ltd.


BrainScope Wins BioHealth Capital Region 5th Annual Crab Trap Competition

BrainScope Wins BioHealth Capital Region 5th Annual Crab Trap Competition

The Bethesda, Maryland based company is helping hospital Emergency Departments (EDs) objectively triage the almost five million patients that present each year with suspected mild traumatic brain injuries. BrainScope’s FDA-cleared decision support tool provides a rapid and accurate assessment of the likelihood of a brain bleed and a concussion, at the point ...

ByBrainScope Company, Inc.


Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease

Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease

CDM technology uses noninvasive MRI brain scan data linked to changes in the brain at a cellular level, offering sensitive and accurate assessment of the neurodegeneration associated with Alzheimer’s disease and other dementias. ...

ByOxford Brain Diagnostics Ltd.


MODAG Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy

MODAG Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy

” Anle138b is a small molecule compound that specifically binds toxic oligomeric structures of alpha-synuclein, the core aggregating protein species in Parkinsonian disorders. ...

ByMODAG GmbH


Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One

Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One

BrainScope One is the first and only FDA-cleared medical device to offer capabilities to assess the full spectrum of brain injury – from concussions (functional abnormality) to brain bleeds (structural injury) – for those with mTBI. ...

ByBrainScope Company, Inc.


BrainScope Honors Veterans Day and Supports U.S. Army Deployment of Traumatic Brain Injury (TBI) and Concussion Assessment Devices

BrainScope Honors Veterans Day and Supports U.S. Army Deployment of Traumatic Brain Injury (TBI) and Concussion Assessment Devices

BrainScope One is the first FDA-cleared medical device to offer multi-modal capabilities to assess brain injury from concussions (functional abnormality) to brain bleeds (structural injury) using EEG and other objective parameters available on a ruggedized, handheld device. ...

ByBrainScope Company, Inc.


BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products

BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products

BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products. BrainScope’s initial product in the market, BrainScope One, is the first FDA-cleared ...

ByBrainScope Company, Inc.


BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product

BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product

BrainScope One is the first FDA-cleared medical device to offer capabilities to assess the full spectrum of brain injury – from concussions (functional abnormality) to brain bleeds (structural injury). ...

ByBrainScope Company, Inc.


NFL & GE Announce Six Final Winners of $10 Million Head Health Challenge

NFL & GE Announce Six Final Winners of $10 Million Head Health Challenge

Innovations are advancing the understanding and diagnosis of mild traumatic brain injury Breakthrough ideas include: point-of-care blood test to rapidly detect the presence of mild and moderate brain trauma; biomarkers that indicate how the brain reacts following a traumatic brain injury (TBI) and a method to identify which ...

ByGeneral Electric


Polystyrene nanoparticles affect fish behaviour and metabolism

Polystyrene nanoparticles affect fish behaviour and metabolism

Fish fed polystyrene nanoparticles are less active and show changes to their brains and metabolism, according to a study by Swedish and Danish researchers. ...

ByEuropean Commission, Environment DG


EFSA assesses potential link between two neonicotinoids and developmental neurotoxicity

EFSA assesses potential link between two neonicotinoids and developmental neurotoxicity

EFSA has delivered its scientific opinion at the request of the European Commission by considering recent research by Kimura-Kuroda[1] and existing data on the potential of acetamiprid and imidacloprid to damage the developing human nervous system - in particular the brain. The PPR Panel found that acetamiprid and imidacloprid may adversely affect the development of neurons and ...

ByThe European Food Safety Authority (EFSA)


Lead Acts to Trigger Schizophrenia

Study in Mice Points to a Synergistic Relationship Between Lead Exposure and Schizophrenia Gene Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia. Scientists at Columbia University’s Mailman School of Public Health and the Johns ...

ByNational Institute of Environmental Health Sciences (NIEHS)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT